Page last updated: 2024-09-04

ampelopsin and Obesity

ampelopsin has been researched along with Obesity in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Miyasaka, K; Shimizu, N; Shimoda, H; Takeda, S; Wu, J; Yamada, W1
Huang, Q; Niu, A; Xia, M; Xiong, X; Yin, T; Zhang, Y1
Feng, SD; He, JQ; Ling, HY; Luo, JD; Lyu, HJ; Wu, D; Yang, SS1
Chen, K; Gong, X; Gu, Y; Lang, H; Mi, M; Ran, L; Wang, X; Zhou, M; Zhou, Q; Zhu, J1
Lang, H; Liu, L; Mi, M; Si, M; Wan, J; Zhou, Y; Zhu, J1

Other Studies

5 other study(ies) available for ampelopsin and Obesity

ArticleYear
The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models.
    Molecules (Basel, Switzerland), 2022, Jan-18, Volume: 27, Issue:3

    Topics: 3T3-L1 Cells; Adiposity; Animals; Anti-Obesity Agents; Antioxidants; Diet, High-Fat; Fatty Liver, Alcoholic; Flavonoids; Lipid Metabolism; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea

2022
Dihydromyricetin contributes to weight loss via pro-browning mediated by mitochondrial fission in white adipose.
    European journal of pharmacology, 2022, Nov-15, Volume: 935

    Topics: 3T3-L1 Cells; Adipocytes, Brown; Adipose Tissue; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Diet, High-Fat; Lipids; Male; Mice; Mice, Inbred C57BL; Mitochondrial Dynamics; Obesity; Weight Loss

2022
[Effects of dihydromyricetin on high fat diet induced obesity in mice and its mechanism].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2020, Jan-28, Volume: 36, Issue:1

    Topics: Adipose Tissue, Brown; Animals; Body Weight; Diet, High-Fat; Flavonols; Male; Mice; Mice, Inbred C57BL; Obesity; Random Allocation

2020
Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN/FNIP1/AMPK pathway.
    Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:6

    Topics: AMP-Activated Protein Kinases; Animals; Carrier Proteins; Dietary Fats; Flavonols; Gene Expression Regulation; Insulin Resistance; Male; Mice; Muscle Fibers, Slow-Twitch; Obesity; Proto-Oncogene Proteins; Signal Transduction; Tumor Suppressor Proteins

2017
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats.
    Molecular and cellular endocrinology, 2017, 01-05, Volume: 439

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Flavonols; Hyperglycemia; Insulin Resistance; Male; Obesity; Rats; Rats, Zucker; Time Factors; Weight Gain

2017
chemdatabank.com